This advancement, which marks a huge leap in surgical robotics, was achieved by the newly launched next generation SSI Mantra 3.
The company said, the surgery is 5 km.
“With the launch of SSI Mantra 3 and the successful completion of India's first human trial in soft tissue telesurgery, we reaffirm our commitment to advance innovation and enhance access in robotic surgery,” said Dr. Sudhir, Founder, Chairman and CEO of SSI Mantra 3. Srivastava said. SS Innovation.
“We are proud to contribute to the Make in India initiative and are dedicated to pushing the boundaries of surgical excellence,” he said.
SSI Mantra 3 is highly advanced and designed to enhance surgical precision, efficiency and patient outcomes by integrating the latest advances in robotic surgery.
It features 5 slimmer robotic arms and an immersive 3D HD headset that provides surgeons with unmatched optics and a vision cart that provides 3D 4K vision to the entire team for precision and control, the company said.
It said the cost-effective pricing of SSI Mantra 3 is aimed at making advanced surgical technologies more accessible to health care institutions in all regions of India and the world.
“The launch of SSI Mantra will take the Indian healthcare system to the forefront globally, especially as telesurgery is now taking place in India,” said Dr. Mylaswamy Annaduari, former Director of ISRO Satellite Center and Board of Directors, SSII.
He said, "India is leading the way in medical science, and it is also racing to help the entire world. The future looks promising, and I am excited to see India leading the way in medical innovation."
The company said, the surgery is 5 km.
“With the launch of SSI Mantra 3 and the successful completion of India's first human trial in soft tissue telesurgery, we reaffirm our commitment to advance innovation and enhance access in robotic surgery,” said Dr. Sudhir, Founder, Chairman and CEO of SSI Mantra 3. Srivastava said. SS Innovation.
“We are proud to contribute to the Make in India initiative and are dedicated to pushing the boundaries of surgical excellence,” he said.
SSI Mantra 3 is highly advanced and designed to enhance surgical precision, efficiency and patient outcomes by integrating the latest advances in robotic surgery.
It features 5 slimmer robotic arms and an immersive 3D HD headset that provides surgeons with unmatched optics and a vision cart that provides 3D 4K vision to the entire team for precision and control, the company said.
It said the cost-effective pricing of SSI Mantra 3 is aimed at making advanced surgical technologies more accessible to health care institutions in all regions of India and the world.
“The launch of SSI Mantra will take the Indian healthcare system to the forefront globally, especially as telesurgery is now taking place in India,” said Dr. Mylaswamy Annaduari, former Director of ISRO Satellite Center and Board of Directors, SSII.
He said, "India is leading the way in medical science, and it is also racing to help the entire world. The future looks promising, and I am excited to see India leading the way in medical innovation."
